Related Experiment Video
Updated: Jun 27, 2026

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity
Published on: December 17, 2013
Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes
1Division of Infectious Diseases, Department of Medicine, AIDS Institute, Geffen School of Medicine, UCLA Medical Center, Los Angeles, CA, USA.
Insights
Current HIV-1 assays detect cytotoxic T lymphocytes (CTL) but not their antiviral activity. A new method measures CTL impact on viral replication, revealing factors influencing HIV-1 control.
Area of Science:
- Immunology
- Virology
- T-cell biology
Background:
- Existing assays accurately detect HIV-1-specific cytotoxic T lymphocytes (CTL).
- However, these methods do not quantify the antiviral efficacy of detected CTL responses.
- Understanding CTL antiviral activity is crucial for HIV-1 pathogenesis and vaccine development.
Purpose of the Study:
- To introduce and validate an experimental approach for measuring the antiviral activity of HIV-1-specific CTL.
- To assess the impact of CTL on HIV-1 replication at the clonal level.
- To elucidate the contributions of both viral and CTL factors to antiviral efficiency.
Main Methods:
- Coculture of HIV-1-specific CTL with HIV-1-infected cells.
- Measurement of viral replication inhibition as a proxy for CTL antiviral activity.
- Analysis of data to identify factors influencing CTL-mediated viral control.
Main Results:
- The developed coculture method allows for the assessment of CTL antiviral efficacy.
- This approach can differentiate CTL responses based on their functional capacity to inhibit viral replication.
- Preliminary data suggest that both viral and CTL characteristics influence antiviral outcomes.
Conclusions:
- A novel experimental system enables the direct measurement of HIV-1-specific CTL antiviral activity.
- This method provides insights into the functional heterogeneity of CTL responses.
- Further studies using this system can elucidate mechanisms of viral control and inform therapeutic strategies.
Abstract:
Currently available assays for detecting HIV-1-specific cytotoxic T lymphocytes (CTL) are remarkable for their technical ease, sensitivity, and precision of measurement. However, it is becoming increasingly apparent that CTL responses vary in their antiviral activity at the clonal level. These assays do not reveal the antiviral efficacies of the CTL they detect. Thus, an experimental approach that has been developed for this purpose has been the coculture of CTL with HIV-1-infected cells, to measure the impact of the CTL on viral replication. Data from such experiments can be useful to elucidate the contribution of viral and CTL factors to the antiviral efficiency of CTL.

